These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 7012070)
21. [Radiotherapy in adults with localized supradiaphragmatic stages CS I/II of Hodgkin's disease. 2. The special aspects of radiotherapy: dosage, fractionation, focal volumes, risks, conclusions]. Glanzmann C; Lütolf UM Strahlenther Onkol; 1993 Oct; 169(10):570-83. PubMed ID: 8235981 [TBL] [Abstract][Full Text] [Related]
22. [ON CLINICAL TRIALS WITH THE CYTOSTATIC ENDOXAN]. SCHULTE-BRINKMANN W; HOHN M Strahlentherapie; 1963 Aug; 121():625-39. PubMed ID: 14061230 [No Abstract] [Full Text] [Related]
23. Surgical quality in trials of adjuvant cancer therapy. Hundahl SA J Surg Oncol; 2002 Aug; 80(4):177-80. PubMed ID: 12210030 [No Abstract] [Full Text] [Related]
24. Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature. Tropé C; Kaern J J Clin Oncol; 2007 Jul; 25(20):2909-20. PubMed ID: 17617522 [TBL] [Abstract][Full Text] [Related]
25. Current aspects of adjuvant therapy of early stage ovarian cancer. McGuire WP Zentralbl Gynakol; 1998; 120(3):93-7. PubMed ID: 9556898 [TBL] [Abstract][Full Text] [Related]
26. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis. Landrum LM; Moore KN; Myers TK; Lanneau GS; McMeekin DS; Walker JL; Gold MA Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126 [TBL] [Abstract][Full Text] [Related]
27. [Adjuvant chemotherapy in patients operated on for early ovarian carcinoma]. Trimbos JB; van der Burg ME Ned Tijdschr Geneeskd; 2004 May; 148(18):874-8. PubMed ID: 15152388 [TBL] [Abstract][Full Text] [Related]
28. Incidence of second solid cancer in patients after treatment of Hodgkin's disease. Glanzmann C; Veraguth A; Lütolf UM Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093 [TBL] [Abstract][Full Text] [Related]
29. Long-term survival in an ovarian cancer patient with brain metastases. Micha JP; Goldstein BH; Hunter JV; Rettenmaier MA; Brown JV Gynecol Oncol; 2004 Mar; 92(3):978-80. PubMed ID: 14984970 [TBL] [Abstract][Full Text] [Related]
30. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis. Fortin D; Gendron C; Boudrias M; Garant MP Cancer; 2007 Feb; 109(4):751-60. PubMed ID: 17211866 [TBL] [Abstract][Full Text] [Related]
31. The dangers of "cross-trial" and "cross-retrospective experience" comparisons: examples employing data in the peer-reviewed ovarian cancer literature. Markman M Cancer; 2007 May; 109(10):1929-32. PubMed ID: 17385206 [No Abstract] [Full Text] [Related]
32. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases]. Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380 [TBL] [Abstract][Full Text] [Related]
33. Management of nonsinonasal neuroendocrine carcinomas of the head and neck. Barker JL; Glisson BS; Garden AS; El-Naggar AK; Morrison WH; Ang KK; Chao KS; Clayman G; Rosenthal DI Cancer; 2003 Dec; 98(11):2322-8. PubMed ID: 14635065 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma. Cheng SH; Tsai SY; Yen KL; Jian JJ; Feng AC; Chan KY; Hong CF; Chu NM; Lin YC; Lin CY; Tan TD; Hsieh CY; Chong V; Huang AT Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):456-65. PubMed ID: 15667967 [TBL] [Abstract][Full Text] [Related]
35. [New approaches to the treatment of advanced ovarian cancer]. Ivanov S Akush Ginekol (Sofiia); 2006; 45(4):20-3. PubMed ID: 16889195 [TBL] [Abstract][Full Text] [Related]
36. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S; J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344 [TBL] [Abstract][Full Text] [Related]
37. Cerebral metastasis from ovarian carcinoma. Some observations about treatment. Cervoni L; Gagliardi FM Minerva Ginecol; 1999; 51(1-2):35-7. PubMed ID: 10230243 [TBL] [Abstract][Full Text] [Related]
38. The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer. Goodheart MJ; Ritchie JM; Rose SL; Fruehauf JP; De Young BR; Buller RE Clin Cancer Res; 2005 May; 11(10):3733-42. PubMed ID: 15897570 [TBL] [Abstract][Full Text] [Related]
39. Unusual site of recurrence in epithelial ovarian carcinoma: Intercostal space metastasis. Deffieux X; Eldweny H; Pocard M; Morice P Eur J Obstet Gynecol Reprod Biol; 2006 Aug; 127(2):264-5. PubMed ID: 16459013 [No Abstract] [Full Text] [Related]
40. Endometrial cancer in premenopausal women 45 years and younger. Gitsch G; Hanzal E; Jensen D; Hacker NF Obstet Gynecol; 1995 Apr; 85(4):504-8. PubMed ID: 7898824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]